Real-world treatment patterns and outcomes of patients with metastatic nonsquamous non-small cell lung cancer after prog…
この記事を読む
記事一覧 11ページ
この記事を読む
KRAS G12Cに対するソトラシブの2年追跡結果
Long-Term Outcomes and Molecular Correlates of Sotorasib Efficacy in Patients With Pretreated KRAS G12C-Mutated Non-Smal…
この記事を読む
EGFR遺伝子変異陽性に対するPACIFICレジメン
Durvalumab After Chemoradiotherapy in Unresectable StageⅢ EGFR-Mutant NSCLC: A Post Hoc Subgroup Analysis From PACIFIC. …
この記事を読む
TTF-1別に免疫複合療法もレジメン選択をすべきか？
Clinical Outcomes of Combined Chemoimmunotherapy in Patients With Advanced Lung Adenocarcinoma: A Prospective Observatio…
この記事を読む
免疫複合療法後の化学療法
Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanc…
この記事を読む
自己申告での喫煙・非喫煙は遺伝子レベルでは少し乖離
Tobacco Smoking-Related Mutational Signatures in Classifying Smoking-Associated and Nonsmoking-Associated NSCLC. Ernst S…
この記事を読む
SBRT後の遠隔転移の予測モデル
Prediction of Distant Metastases After Stereotactic Body Radiation Therapy for Early Stage NSCLC: Development and Extern…
この記事を読む
術前免疫療法後のPETでMPRを予測する
Utility of 18F-FDG PET/CT uptake values in predicting response to neoadjuvant chemoimmunotherapy in resectable non-small…
この記事を読む
ニボルマブ＋イピリムマブの長期成績
Long-term survival with first-line nivolumab plus ipilimumab in patients with advanced non-small-cell lung cancer: a poo…
この記事を読む
TKI使用後T790M陰性に対するオシメルチニブ
A phase II study (WJOG12819L) to assess the efficacy of osimertinib in patients with EGFR mutation-positive NSCLC in who…